Expression feature and prognostic function of a novel immune checkpoint Siglec-15 in human colorectal cancer.
Collectively, the data suggested that Siglec-15 expression may serve as a novel prognostic factor and Siglec-15 might be identified as an ideal candidate for immunotherapy in CRC treatment.
Authors
- Yidan Zhu (ORCID: https://orcid.org/0000-0002-4427-3946)
- Wen Huang (ORCID: https://orcid.org/0000-0001-9664-1707)
- Junrong Yang
- Linyun Zhou
- Xu Li (ORCID: https://orcid.org/0000-0002-2040-3128)
- Fan Yang (ORCID: https://orcid.org/0000-0001-9604-913X)
- Guodong Liang (ORCID: https://orcid.org/0009-0008-6278-0379)
- Run Ding
Institutions
- Chinese PLA General Hospital (CN)
- Jiangsu Cancer Hospital (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.14670/hh-18-801
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00